These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19579227)

  • 1. Intention to treat, per protocol, as treated and instrumental variable estimators given non-compliance and effect heterogeneity.
    McNamee R
    Stat Med; 2009 Sep; 28(21):2639-52. PubMed ID: 19579227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating treatment effects in randomised controlled trials with non-compliance: a simulation study.
    Ye C; Beyene J; Browne G; Thabane L
    BMJ Open; 2014 Jun; 4(6):e005362. PubMed ID: 24939814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simple Estimation of Patient-Oriented Effects From Randomized Trials: An Open and Shut CACE.
    Steele RJ; Shrier I; Kaufman JS; Platt RW
    Am J Epidemiol; 2015 Sep; 182(6):557-66. PubMed ID: 26283090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regaining power lost by non-compliance via full probability modelling.
    Becque T; White IR
    Stat Med; 2008 Nov; 27(27):5640-63. PubMed ID: 18712776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of treatment efficacy with complier average causal effects (CACE) in a randomized stepped wedge trial.
    Gruber JS; Arnold BF; Reygadas F; Hubbard AE; Colford JM
    Am J Epidemiol; 2014 May; 179(9):1134-42. PubMed ID: 24705812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A synthetic estimator for the efficacy of clinical trials with all-or-nothing compliance.
    Antonelli J; Han B; Cefalu M
    Stat Med; 2017 Dec; 36(29):4604-4615. PubMed ID: 28833307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simple efficient bias corrected instrumental variable estimator for randomized trials with noncompliance.
    Chan KC
    Contemp Clin Trials; 2012 Jul; 33(4):786-93. PubMed ID: 22484340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond intent to treat (ITT): A complier average causal effect (CACE) estimation primer.
    Peugh JL; Strotman D; McGrady M; Rausch J; Kashikar-Zuck S
    J Sch Psychol; 2017 Feb; 60():7-24. PubMed ID: 28164801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bias analysis of the instrumental variable estimator as an estimator of the average causal effect.
    Chiba Y
    Contemp Clin Trials; 2010 Jan; 31(1):12-7. PubMed ID: 19879376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Complier Average Causal Effect Parameter for Multiarmed RCTs.
    Schochet PZ
    Eval Rev; 2020 Oct; 44(5-6):410-436. PubMed ID: 33375826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interval estimation of the risk difference in non-compliance randomized trials with repeated binary measurements.
    Lui KJ
    Stat Med; 2007 Jul; 26(16):3140-56. PubMed ID: 17177272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Model misspecification sensitivity analysis in estimating causal effects of interventions with non-compliance.
    Jo B
    Stat Med; 2002 Nov; 21(21):3161-81. PubMed ID: 12375297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple imputation methods for treatment noncompliance and nonresponse in randomized clinical trials.
    Taylor L; Zhou XH
    Biometrics; 2009 Mar; 65(1):88-95. PubMed ID: 18397338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On estimating treatment effects under non-compliance in randomized clinical trials: are intent-to-treat or instrumental variables analyses perfect solutions?
    Bang H; Davis CE
    Stat Med; 2007 Feb; 26(5):954-64. PubMed ID: 16900559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beyond intention to treat: what is the right question?
    Shrier I; Steele RJ; Verhagen E; Herbert R; Riddell CA; Kaufman JS
    Clin Trials; 2014 Feb; 11(1):28-37. PubMed ID: 24096636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficiency and robustness of causal effect estimators when noncompliance is measured with error.
    Boatman JA; Vock DM; Koopmeiners JS
    Stat Med; 2018 Dec; 37(28):4126-4141. PubMed ID: 30109713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A causal model for longitudinal randomised trials with time-dependent non-compliance.
    Becque T; White IR; Haggard M
    Stat Med; 2015 May; 34(12):2019-34. PubMed ID: 25778798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient Centered Hazard Ratio Estimation Using Principal Stratification Weights: Application to the NORCCAP Randomized Trial of Colorectal Cancer Screening.
    MacKenzie TA; Løberg M; O'Malley AJ
    Obs Stud; 2016 Mar; 2():29-50. PubMed ID: 29644344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Per-Protocol analyses produced larger treatment effect sizes than intention to treat: a meta-epidemiological study.
    Mostazir M; Taylor G; Henley WE; Watkins ER; Taylor RS
    J Clin Epidemiol; 2021 Oct; 138():12-21. PubMed ID: 34161805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dichotomizing partial compliance and increased participant burden in factorial designs: the performance of four noncompliance methods.
    Merrill PD; McClure LA
    Trials; 2015 Nov; 16():523. PubMed ID: 26573840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.